Filing Flows

Filing Flows › Elanco Animal Health (ELAN) › Q1 2026

Elanco Animal Health (ELAN) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 6, 2026

Elanco Animal Health (ELAN) reported revenue of $1.4B for the first quarter 2026 (Q1 2026), +15% from a year earlier and +20% from the quarter before. Operating margin was 6.3%, net earnings $57.0M (4.2% of revenue).

Revenue$1.4B
Year over year+15%
Quarter over quarter+20%
Operating margin6.3%
Net earnings$57.0M

Elanco Animal Health, Q1 2026: revenue $1.4B (+15% year over year), operating margin 6.3%, net earnings $57.0M, operating cash flow $13.0M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$1.4B+20%+15%
Gross profit$785M+33%+15%
Operating profit$87.0M—+45%
Net earnings$57.0M—-15%
Operating cash flow$13.0M-88%—

What changed

Revenue was $1.4B in Q1 2026, up 15% year over year and up 20% from the previous quarter. Pet Health was the largest line at 52% of revenue. Pet Health added $0.07B year over year (up 12%), 42% of the total change.

Gross margin was 57.3%, down 0.1 points from Q1 2025. Operating profit was $0.09B, a 6.3% margin (up 1.3 points year over year). Of the extra revenue versus Q1 2025, 15% reached operating profit, above the 5% margin then. Operating expenses grew 12% against revenue growth of 15%. The fastest-growing cost line was Other operating costs (+16%). Net earnings were $0.06B, down 15% year over year. The effective tax rate was 34.5%.

Operating cash flow was $0.01B, 23% of net earnings. Non-cash charges added back $0.17B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.24B. Capital expenditures of $0.05B exceeded it, leaving free cash flow of −$0.04B.

Questions

What was Elanco Animal Health's revenue in the first quarter 2026?

Elanco Animal Health (ELAN) reported revenue of $1.4B for the first quarter 2026 (Q1 2026), +15% from a year earlier and +20% from the quarter before.

Was Elanco Animal Health profitable in the first quarter 2026?

Operating profit was $87.0M (6.3% of revenue) and net earnings $57.0M.

Open the interactive Sankey →

Source: Elanco Animal Health 10-Q on SEC EDGAR.